LU91963I

The invention relates to 8a-azalides which are used for the treatment and prevention of respiratory and enteral infections in animals, in particularly in cattle and pigs. The compounds are applied in a therapeutical and prophylactic effective quantity ensuring a level of antibacterial activity in th...

Full description

Saved in:
Bibliographic Details
Main Authors Wilkening Robert D, Clark Jeffrey N, Ratcliffe Jeffrey W, Kropp Helmut, Farrington Daniel O
Format Patent
LanguageFrench
Published 02.01.2019
Subjects
CHEMISTRY
DERIVATIVES THEREOF
HETEROCYCLIC COMPOUNDS
HUMAN NECESSITIES
HYGIENE
MEDICAL OR VETERINARY SCIENCE
METALLURGY
NUCLEIC ACIDS
NUCLEOSIDES
NUCLEOTIDES
ORGANIC CHEMISTRY
PREPARATIONS FOR MEDICAL, DENTAL, OR TOILET PURPOSES
SPECIFIC THERAPEUTIC ACTIVITY OF CHEMICAL COMPOUNDS ORMEDICINAL PREPARATIONS
SUGARS
Online AccessGet full text

Cover

More Information
Summary:The invention relates to 8a-azalides which are used for the treatment and prevention of respiratory and enteral infections in animals, in particularly in cattle and pigs. The compounds are applied in a therapeutical and prophylactic effective quantity ensuring a level of antibacterial activity in the organism in the animals sufficient to inhibit the bacterial pathogenous agents of respiratory infections: Pasteurella haemolytica, P. multocida,Haemophilus somnus and Mycoplasma spp. in cattle, and Pasteurella multocida, Actinobacillus pheuropneumoniae and Mycoplasma spp. in pigs.
Bibliography:Application Number: LU20120091963C